Tesla, Apple, Ford, Southwest Airlines, Hoth Therapeutics: Why These Five Stocks Are Drawing Investors' Attention Today?

Major Wall Street indices closed over 1% higher on Thursday after the much-awaited year-end rally materialized in the form of dip-buying. The Nasdaq Composite closed 2.59% higher while the S&P 500 rose 1.75%. The Dow gained 1.05%. Here are the five stocks that are drawing investors’ attention:

Also Read: How To Invest In Startups

1. Tesla Inc (NASDAQ:TSLA): Shares of Tesla ended 8.08% higher on Thursday. The rally continued from Wednesday’s rebound following Elon Musk’s call to employees asking them not to be "bothered by stock market craziness." In an email — sent to staff on Wednesday, which Reuters reviewed — Musk said he believes Tesla will be the most valuable company on earth in the long term.

2. Apple Inc (NASDAQ:AAPL): Apple shares ended 2.83% higher on Thursday. The iPhone maker’s primary chipmaker Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM) has commenced mass production of its most advanced chips in southern Taiwan.

3. Ford Motor Company (NYSE:F): Shares of Ford closed 5.39% higher on Thursday. The Treasury Department said on Thursday that electric vehicles leased by consumers can qualify for up to $7,500 in commercial clean vehicle tax credits beginning 2023, reported Reuters. The Internal Revenue Service released an initial list of eligible 2023 EVs, which includes Ford, Rivian Automotive Inc (NASDAQ:RIVN), Chrysler-parent Stellantis NV (NYSE:STLA), and Nissan, the report said.

4. Southwest Airlines Co (NYSE:LUV): Southwest Airlines said it plans to return to normal operations on Friday following days of running at a third of its usual capacity owing to disruptions caused by a massive winter storm, reported Reuters. Shares of the company closed 3.7% higher.

5. Hoth Therapeutics Inc (NASDAQ:HOTH): Shares of the company closed 143.64% higher on Thursday. The Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment of rash and skin disorders, it said in a statement.

Read Next: 10 Highest-Yielding Dow Jones Stocks Heading Into 2023